INTRODUCTION
In 1911, Forssman (1) produced high titers of sheep hemolysins by immunization of rabbits with aqueous suspension of guinea pig organs, which marked the beginning of an intensive period of investigation of the occurrence and distribution in nature of heterophile antigens, i.e., antigens shared by unrelated species. Forssman antigens have been found in the tissues of many mammals, birds, and fish as well as in a wide spectrum of micro-organisms. Of particular interest to this study is the presence of the Forssman antigen in sheep and its absence in the rat; man is a Forssman--negative species, although Forssman-like antigens have been described in subjects of blood groups A and AB (2) .
A multiplicity of other heterophile antigens has been identified since 1911, including antigens shared by human erythrocytes and Gram-negative microorganisms (3, 4) and antigens common toc group A human erythrocytes and pneumococci (5-7)-pneumococcus Type XIV in particular (8, 9) . The existence of similar antigens in microorganisms and mammalian tissues has been proposed by many authors as an explanation for the occurrence of serum antibodies encountered in some infectious diseases. Notable examples in this; regard are the sheep hemolysins and hemagglutinins described in serum sickness (10, 11) and in infectious mononucleosis (12) (13) (14) (15) , as well as the observation that normal mammalian tissues, such as bovine heart, contain a thermostable, ethanolsoluble substance active as an antigen in the serological tests for syphilis (16) .
Kaplan and associates (17) (18) (19) (20) , , and Zabriskie and Freimer (24) have recently provided cogent evidence of cross-reactions between group A streptococcal antigens and mammalian tissue components, and Brent, Medawar, and Ruszkiewicz (25) have described cross-reactions between pneumococcal polysaccharides and the transplantation antigens of A-strain mice. In addition, the demonstration that heat-killed group A streptococci induce in mice, rats, guinea pigs, and rabbits a state of hypersensitivity to skin allografts, which is indistinguishable from that resulting from pretreatment of the recipients with allogeneic tissues (26) (27) (28) (29) (30) , has provided evidence that stimulation by heterologous antigens may be operative in conditioning host responses to tissue transplants.
In view of the difficulty in demonstrating serum antibodies to tissue allotransplants-particularly before completion of graft rejection and/or excision of the transplant (31, 32) , it appeared of interest to attempt to extend the concept of an involvement of heterophile antigens in transplantation to an assessment of possible serological components of allograft responses in man. Preliminary observations have indicated that rejection of skin allografts was associated in human recipients with the development of agglutinins against sheep, guinea pig, and rat erythrocytes (33, 34) . The present report confirms and extends these observations, and analyzes posttransplantation heterophile antibody responses in 49 recipients of leukocyte extracts and skin allografts, and in 22 recipients of kidney transplants. The results are compared with similar antibody determinations -performed on sera obtained from 86 normal subjects, 19 multiparous women, and a battery of 30 typing sera recognizing the major leukocyte group antigens of the Hu-1 system of human histocompatibility (35, 36) .
METHODS

Human sera
Skin transplantation sera were obtained from 49 healthy volunteers who served for studies described in detail in previous papers (37, 38) . Each recipient was sensitized with leukocytes or their fractions and, 2 wk later, received a skin graft from the same donor. The methods for preparation of antigenic materials used for sensitization as well as the procedure of grafting and of graft observation have been described previously (38) . Pretreatment serum samples were obtained from each recipient; after sensitization, we collected sequential serum samples at weekly intervals until the 4th wk after graft rejection.
Sera from 22 kidney allograft recipients were kindly supplied by Drs. S. Anthone and R. Anthone of the Buffalo General Hospital, Buffalo, N. Y., Drs. J. P. Merrill and R. J. Glassock of the Peter Bent Brigham Hospital, Boston, Mass., Drs. D. Hume and G. M. Williams of the Medical College of Virginia, Richmond, Va., and Dr. T. E. Starzl of the Denver Veterans Administration Hospital, Denver, Colo. Pretransplantation sera, as well as a minimum of 10-serial samples obtained after operation were tested for each patient. The subjects were ABO-group compatible with the graft donors. They were all maintained on standard imunosuppressive therapy with azathioprine and prednisone. The majority of the recipients suffered at least one rejection crisis during the period of testing.
30 leukocyte typing sera recognizing 131 major histocompatibility antigens of the Hu-1 system (35) were obtained through the courtesy of Dr. J. tausset of the H6pital Saint-Louis, Paris, France; anti-6A serum was kindly supplied by Dr. J. van Rood, of the University of Leiden. In addition to such typing sera, 19 sera of multiparous women, which contained leukoagglutinins, were included in this study. Sera of 86 healthy blood donors were tested for control purposes. All sera were preserved at -220C and were inactivated at 560C for 30 min before use.
Rabbit antisera
Antisera to the heterophile agglutinins detected in this study were prepared in four albino rabbits. Washed and packed erythrocytes of Wistar-strain rats were mixed with equal volumes of undiluted pooled serum obtained from skin graft recipients BER, BRO, GER, and WEIS, who had formed potent anti-rat hemagglutinins. The mixture was incubated for 1 hr at room temperature. The agglutinated erythrocytes were then washed four times and resuspended to a 10% concentration in phosphatebuffered saline (PBS), pH 7.2. Each rabbit received nine intravenous injections of 10 ml of such suspensions at 2-3-day intervals. 1 wk after the last injection, the animals were exsanguinated and the antisera were separated.
Rabbit antiserum to pooled normal human serum purchased from Hyland Laboratories, Los Angeles, Calif., was also used in the course of this study. 
Erythrocytes
Absorption of human sera
Transplantation sera which contained high titers of heterophile hemagglutinins were selected for absorption experiments; 0.5 ml of washed packed erythrocytes of each species tested (human, ox, sheep, monkey, rabbit, guinea pig, and rat) were added to 1 ml of a 1: 8 dilution of each serum sample. The mixture was shaken on an electric shaker for 30 min, and was left at room temperature for another 30 min. The suspension was then centrifuged at 1470 g for 10 min. The supernatant serum was absorbed once more in similar fashion.
Treatment with sulfhydryl compound (39) Selected human transplantation serum samples were diluted to 1: 4 and incubated with equal volumes of 0.2 M 2-mercaptoethanol at 370C for 1 hr. They were then immediately used in hemagglutination tests.
Immunoelectrophoresis
We followed the modification described by Scheidegger (40) using 1.5% agar in barbital buffer of pH 8.6 at an ionic strength of 0.075.
Preparative ultracentrifugation
The procedure of Brakke (41), modified by Fudenberg and Kunkel (42) was used. Briefly, 0.5 ml of serum tested, at a dilution corresponding to 32-64 agglutinating U, was layered over a sucrose density gradient (1040%).
Separation was performed in a swinging bucket rotor (Spinco ultracentrifuge) at 95,700 g for 16 hr. Successive fractions were obtained by the drop collection procedure and examined in the hemagglutination test after dialysis against saline.
RESULTS
Heterophile hemagglutinins in human transplant recipients Sera of 49 recipients of human transplantation antigens and skin allografts were tested. In pretreatment serum samples, the mode titers of natural heteroagglutinins were 5 for sheep and guinea pig erythrocytes, and 40 for rat erythrocytes. Rises in titer were observed after skin transplantation in 33 recipients. There were 24 individuals with a minimum eightfold increase in antibody titer against at least one erythrocyte species. Table I lists these individuals; it is noted that 18 recipients had rises in sheep hemagglutinins, with some titers as high as 640; 20 subjects had rises in guinea pig hemagglutinins, in some instances as high as 1280, and 21 individuals had hemagglutinin levels noted after titer. In 10 instances, the titer increased by a factor of 8 or more after transplantation; the highest titer observed was 1280.
The results observed appeared in some instances to bear a relation to the clinical state of the patients, since peak antibody titers were associated with impending rejection crises.
Heterophile hemagglutinins in normal individuals and in multiparous women
Titers of 20 provided a useful dividing line between naturally occurring and induced agglutinins to sheep and guinea pig erythrocytes. In the case of rat hemagglutinins, this titer was 40. As noted in Table III Table IV illustrates some representative reactions obtained in the course of cross-absorption experiments designed to assess the specificity of posttransplantation heterophile antibodies. Since many posttransplant sera had the capacity to agglutinate ox and rhesus monkey erythrocytes, these two species were included in the experiment. Erythrocytes from each of the five species tested regularly removed from the serum the hemagglutinating activity directed against that same species. A certain degree of cross-reactivity was also noted, however, in that erythrocytes of each species were capable of absorbing some hemagglutinins directed against the other species. Rat and ox erythrocytes were the most effective cells in this regard.
An anti-6A serum, which gave strong leukoagglutinating reactions with leukocytes positive for group 6A of van Rood, was also absorbed with rat erythrocytes. In three consecutive experiments, this procedure completely removed the leukoagglutinating activity of this serum.
(b) Effects of 2-mercaptoethanol. Table V illustrates an experiment designed to assess the effect of 2-mercaptoethanol on posttransplant heterophile antibodies. In this particular experiment7
hemagglutinating activity was completely abolished by mercaptoethanol in three sera, but was not significantly affected in the two remaining sera. Similar results were obtained in other experiments; treatment with 2-mercaptoethanol abolished. heterophile hemagglutinating activity in 17 sera,.
but had no effect upon sera obtained from severz other recipients. (c) Sucrose density gradient ultracentrifugation studies. Table VI illustrates the results of fractionation of posttransplant sera by sucrose density gradient ultracentrifugation, before and after treatment with 2-mercaptoethanol. The hemagglutinating activity of sera obtained from skin allograft recipients BER and WEIS was recovered in the IgG and IgM containing fractions, while only the IgM containing fractions of sera from kidney allograft subjects LAN and HEC showed such activ- * Serum specimens used for this experiment were not the same which were used in the titrations reported in Tables I and   III. ity. The hemagglutinating activity of the IgM containing fractions was regularly abolished by treatment of the sera with 2-mercaptoethanol before ultracentrifugation.
(d) Immunoelectrophoretic studies. In order to obtain further information as to the immunoglobulin nature of the posttransplantation heterophile hemagglutinins, we immunized rabbits with rat erythrocytes agglutinated by a pool of four human sera containing potent anti-rat hemagglutinins. The resulting rabbit antisera were studied by immunoelectrophoresis against whole human serum, and against Fraction II thereof. As illustrated in Fig. 1 (43) , and by Davidsohn and Lee (44) of heterophile antibody responses after the injection of blood group substances into human recipients raised the possibility that the antibodies detected in this study were a result of this type of antigenic stimulus. However, absorption of positive sera with human A and/or B erythrocytes failed to remove the heterophile hemagglutinins. In addition, such heterophile antibody responses occurred in many ABO-group compatible donor-recipient combinations, and failed to occur in a significant number of ABO-incompatible situations. It therefore appears to be unlikely that ABO group antigens played a significant role in this type of allograft response.
The ability of the heterophile antibodies to agglutinate erythrocytes of Forssman-negative species (rat, monkey, and ox), as well as the capacity of such erythrocytes to absorb posttransplant anti-sheep hemagglutinins exclude the possibility that these antibodies are of the Forssman category. In (46) .
It may also be a result of the uremic status of the recipients at the time of kidney transplantation (47) , and of the use of immunosuppressive agents in this group of individuals (48) .
The data with sera obtained from multiparous women confirm Litschel's (49) report that such sera contain low titers of anti-sheep hemagglutinins. In the present study, such titers seldom exceeded 20. There were slightly higher titers of anti-guinea pig and anti-rat hemagglutinins in this group, although they were not comparable with antibody titers observed in allograft recipients. This observation is in agreement with the concept of the privileged intra-uterine status of the "fetal allograft" (50) . Since peak titers of heterophile antibodies were observed in association with allograft rejection, the possibility should be considered that such antibodies may constitute a response .to antigens released or exposed as a result of tissue damage. Such antigens, which could resemble antigens normally present in heterologous species, have been implicated in mechanisms associated with the formation of rheumatoid factor (51) and with the triggering of autoimmune diseases (52) . Recent reports of the appearance of rat hemagglutinins in the guinea pig, rabbit, and man as a result of thermal injury (53) lend further support to this interpretation.
The ability of human recipients to develop serum antibody responses to erythrocytes of foreign species after transplantation bears further witness to the ubiquitous nature of the antigenic determinants involved in mammalian allograft reactions (29) . Regardless of its origins, this type of immunological reactivity may be of direct pertinence to further studies of the precise nature of human transplantation antigens and of their distribution in group fashion in unrelated individuals. Not all allograft recipients whose serological responses have been assessed in the course of this study developed significant heterophile antibody titers at the time of graft rejection. The presence or absence of this response may indeed be an expression of variations in the antigenic differences existing between donor and recipient. Peak titers of heterophile hemagglutinins-antirat agglutinins in particular-have been associated in a number of instances, however, with skin or kidney allograft rejection. A demonstration of rising titers of heterophile antibodies might therefore provide an early warning system for the diagnosis and prompt management of rejection crises in those cases of clinical organ transplantation where the antigenic differences between donor and recipient are capable of evoking this type of response.
